ArticleJournal of clinical medicine2026

Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey.

Mehmet Bakırtaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.